Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, CEO of Mammoth Biosciences, who was featured on Forbes 2019 Healthcare 30 Under 30. Trevor is a 29-year-old S [...]
November 16, 2018 3:30 - 5pm After closing a $35 million Series B, ViewPoint Therapeutics will be moving to their own lab space in South San Francisco. They were one of the very first companies to m [...]
November 1st, 2018 3:30-6pm Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live b [...]
Cell Design Labs wins big with Gilead acquisition.
ViewPoint develops a nonsurgical route to cataract treatment.
Alector reaches $425M in funding and enters two programs into clinical trials.
September 13, 2018Agenda:1:00-3:00pm: Amgen Office Hours3:15-4:15pm: Amgen Seminar “Unlocking the potential of biology for patients”4:15-6:00pm: Happy Hour / NetworkingPlace: 953 Indiana Street, San F [...]